R&G Associates

Recent papers from R&G Associates

1. Automated Check-Ins to Care Assistant? The Use of Kiosks in the School Health RoomNASN School Nurse · 2026
2. Memory on ice: spatial memory is retained over a 9-month hibernation period in Columbian ground squirrelsBiology Letters · 2026
3. Oxidation Behaviour of HVAF Sprayed Al0.3CrFeNiTi0.3 High Entropy Alloy CoatingJournal of Thermal Spray Technology · 2026
4. Real-world treatment patterns and clinical outcomes for patients with deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC).Journal of Clinical Oncology · 2026
5. Depression detectives: piloting a methodology for online co-produced researchResearch Involvement and Engagement · 2026
6. CALPHAD-guided design of a Co-free medium-entropy alloy laser-clad coatingJournal of Alloys and Compounds · 2026
7. A primary care approach to bereavementBritish Journal of General Practice · 2026
8. Development of an optimal pathway for endoscopic sleeve gastroplasty implementation in the NHS: a modified nominal group technique studyBMJ Open Gastroenterology · 2026
9. A pilot feasibility study of teaching focused cardiac ultrasound to Australian medical students in a structured programBMC Medical Education · 2025
10. A Pragmatic Approach to Improving Management and Patient Flow for Painful Diabetic Neuropathy in UK Primary CareDiabetes Therapy · 2025
11. The Potential Impact of Primary Care-Based Multiplex Polymerase Chain Reaction Point of Care Testing for Viral Acute Respiratory Infections in the UK: Modified Delphi StudyHealth Services Insights · 2025
12. Preliminary Survey of Horse Mussels (Modiolus modiolus) in the Voluntary Berwickshire Marine Reserve, East Coast ScotlandJournal of Marine Science and Engineering · 2025
13. Practical Approaches to Continuous Glucose Monitoring in Primary Care: A UK-Based Consensus OpinionDiabetes Therapy · 2025
14. Anti-HLA antibodies may be a subset of polyreactive immunoglobulins generated after viral superinfectionTransplant Immunology · 2025
15. Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysisHealth Technology Assessment · 2024
16. SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative ReviewDiabetes Therapy · 2024
17. Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15PharmacoEconomics - Open · 2023
18. Using the learning disability screening questionnaire to help identify people with an intellectual disability in homeless servicesJournal of Applied Research in Intellectual Disabilities · 2023
19. Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology AppraisalPharmacoEconomics - Open · 2023
20. Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology AppraisalPharmacoEconomics - Open · 2023